1,542
Views
8
CrossRef citations to date
0
Altmetric
Research Articles

Mechanochemical preparation of triptolide-loaded self-micelle solid dispersion with enhanced oral bioavailability and improved anti-tumor activity

ORCID Icon, , , , , , , , & show all
Pages 1398-1408 | Received 02 Mar 2022, Accepted 18 Apr 2022, Published online: 09 May 2022

References

  • Bahri M, Kazemian H, Rohani S. (2016). Mechanochemical synthesis of CPM-5: a Green method. J Chem Eng Technol 40:88–93.
  • Bernela M, Ahuja M, Thakur R. (2016). Enhancement of anti-inflammatory activity of glycyrrhizic acid by encapsulation in chitosan-katira gum nanoparticles. Eur J Pharm Biopharm 105:141–7.
  • Boldyrev VV. (2005). Mechanochemical modification and synthesis of drugs. J ChemInform 36:5117–20.
  • Chen H, Chang X, Weng T, et al. (2004). A study of microemulsion systems for transdermal delivery of triptolide. J Control Release 98:427–36.
  • Chou CC, Yang JS, Lu HF, et al. (2010). Quercetin-mediated cell cycle arrest and apoptosis involving activation of a caspase cascade through the mitochondrial pathway in human breast cancer MCF-7 cells. Arch Pharm Res 33:1181–91.
  • Dasa SSK, Suzuki R, Gutknecht M, et al. (2015). Development of target-specific liposomes for delivering small molecule drugs after reperfused myocardial infarction. J Control Release 220:556–67.
  • Deng QD, Lei XP, Zhong YH, et al. (2021). Triptolide suppresses the growth and metastasis of non-small cell lung cancer by inhibiting β-catenin-mediated epithelial-mesenchymal transition. Acta Pharmacol Sin 42:1486–97.
  • Descamps M, Willart JF. (2016). Perspectives on the amorphisation/milling relationship in pharmaceutical materials. Adv Drug Deliv Rev 100:51–66.
  • Geszke-Moritz M, Moritz M. (2016). Solid lipid nanoparticles as attractive drug vehicles: composition, properties and therapeutic strategies. Mater Sci Eng C Mater Biol Appl 68:982–94.
  • Gu C, Liu F, Luo X, et al. (2016). Triptolide reduces the required dose of tacrolimus by attenuating inflammation, enhancing immunosuppression, and increasing donor chimerism in a heterotopic hindlimb transplantation model. Plast Reconstr Surg 138:1243–53.
  • Jiang W, Chen M, Xiao C, et al. (2019). Triptolide suppresses growth of breast cancer by targeting HMGB1 in vitro and in vivo. Biol Pharm Bull 42:892–9.
  • Li SD, Huang L. (2008). Pharmacokinetics and biodistribution of nanoparticles. Mol Pharm 5:496–504.
  • Ling D, Xia H, Park W, et al. (2014). pH-sensitive nanoformulated triptolide as a targeted therapeutic strategy for hepatocellular carcinoma. ACS Nano 8:8027–39.
  • Liu D, Mori A, Huang L. (1992). Role of liposome size and RES blockade in controlling biodistribution and tumor uptake of GM1-containing liposomes. Biochim Biophys Acta 1104:95–101.
  • Liu L, Xiong X, Shen M, et al. (2018). Co-delivery of triptolide and curcumin for ovarian cancer targeting therapy via mPEG-DPPE/CaP nanoparticle. J Biomed Nanotechnol 14:1761–72.
  • Malik NA. (2016). Solubilization and interaction studies of bile salts with surfactants and drugs: a review. Appl Biochem Biotechnol 179:179–201.
  • Monteiro N, Martins A, Reis RL, et al. (2014). Liposomes in tissue engineering and regenerative medicine. J R Soc Interface 11:20140459.
  • Pompei R, Laconi S, Ingianni A. (2009). Antiviral properties of glycyrrhizic acid and its semisynthetic derivatives. Mini Rev Med Chem 9:996–1001.
  • Ren Q, Li M, Deng Y, et al. (2021). Triptolide delivery: nanotechnology-based carrier systems to enhance efficacy and limit toxicity. Pharmacol Res 165:105377.
  • Ridolfo R, Ede BC, Diamanti P, et al. (2018). Biodegradable, drug-loaded nanovectors via direct hydration as a new platform for cancer therapeutics. Small (Weinheim an Der Bergstrasse, Germany) 14:e1703774.
  • Su X, Wu L, Hu M, et al. (2017). Glycyrrhizic acid: a promising carrier material for anticancer therapy. Biomed Pharmacother 95:670–8.
  • Sun Q, Zhou Z, Qiu N, et al. (2017). Rational design of cancer nanomedicine: nanoproperty integration and synchronization. Adv Mater 29:1606628.
  • Sun X, Zhu D, Cai Y, et al. (2019). One-step mechanochemical preparation and prominent antitumor activity of SN-38 self-micelle solid dispersion. Int J Nanomedicine 14:2115–26.
  • Tian L, Zhang Y, Wang Y, et al. (2019). Triptolide reduces proliferation and enhances apoptosis in drug-resistant human oral cancer cells. Int J Clin Exp Pathol 12:1204–13.
  • Wang X, Gao Y. (2018). Effects of length and unsaturation of the alkyl chain on the hydrophobic binding of curcumin with Tween micelles. Food Chem 246:242–8.
  • Wang K, Guo C, Zou S, et al. (2018). Synthesis, characterization and in vitro/in vivo evaluation of novel reduction-sensitive hybrid nano-echinus-like nanomedicine. Artif Cells Nanomed Biotechnol 46:659–67.
  • Wang X, Zhang S, Zhao H, et al. (2021). Spectroscopic investigation into the binding of erulic acid with sodium deoxycholate: hydrophobic force versus hydrogen bonding. Langmuir 37:1420–8.
  • Wei G, Li Y, Zhang L, et al. (2018). Synthesis of bentonite-supported Fe(II) and heteropolyacid (HPW) composite through a mechanochemical processing. J Appl Clay Sci 152:342–51.
  • Xu L, Qiu Y, Xu H, et al. (2013). Acute and subacute toxicity studies on triptolide and triptolide-loaded polymeric micelles following intravenous administration in rodents. Food Chem Toxicol 57:371–9.
  • Xu W, Wen M, Yu J, et al. (2018). Mechanochemical preparation of kaempferol intermolecular complexes for enhancing the solubility and bioavailability. Drug Dev Ind Pharm 44:1924–32.
  • Xue M, Zhao Y, Li XJ, et al. (2012). Comparison of toxicokinetic and tissue distribution of triptolide-loaded solid lipid nanoparticles vs free triptolide in rats. Eur J Pharm Sci 47:713–7.
  • Yang S, Chen J, Guo Z, et al. (2003). Triptolide inhibits the growth and metastasis of solid tumors. Mol Cancer Ther 2:65–72.
  • Ye J, Li R, Yang Y, et al. (2021). Comparative colloidal stability, antitumor efficacy, and immunosuppressive effect of commercial paclitaxel nanoformulations. J Nanobiotechnol 19:199.
  • Yu L, Wang Z, Mo Z, et al. (2021). Synergetic delivery of triptolide and Ce6 with light-activatable liposomes for efficient hepatocellular carcinoma therapy. Acta Pharm Sin B 11:2004–15.
  • Zhang C, Peng F, Liu W, et al. (2014). Nanostructured lipid carriers as a novel oral delivery system for triptolide: induced changes in pharmacokinetics profile associated with reduced toxicity in male rats. IJN 9:1049–63.
  • Zhang Q, Polyakov NE, Chistyachenko YS, et al. (2018). Preparation of curcumin self-micelle solid dispersion with enhanced bioavailability and cytotoxic activity by mechanochemistry. Drug Deliv 25:198–209.
  • Zhu J, Zheng S, Liu H, et al. (2021). Evaluation of anti-tumor effects of crocin on a novel 3D tissue-engineered tumor model based on sodium alginate/gelatin microbead. Int J Biol Macromol 174:339–51.